
Stopping DMTs in Older MS Patients: What the Data Show
WEST PALM BEACH, Florida — Discontinuing disease-modifying therapies (DMTs) for multiple sclerosis (MS) after prolonged disease stability poses minimal risk for patients aged > 60 years, highlighting the importance of weighing the potential harms of …